With the analysis among 555 patents, we discovered top 179 key players by total patent application. Genzyme Corp., Boehringer Ingelheim International GmbH, Bayer Healthcare Co., Ltd. are dominant in this area. They take 25.41% of the total patent filing.
Massachusetts, United States
Patent: 83
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 34
Bayer Healthcare Co., Ltd.
Beijing Shi, China
Patent: 24
California, United States
Patent: 15
William A. Cook Australia Pty Ltd.
Tokyo-to, Japan
Patent: 12
Shanghai Ruiyu Biotech Co., Ltd.
Shanghai Shi, China
Patent: 12
Coherus BioSciences, Inc.
California, United States
Patent: 11
Fukushima-ken, Japan
Patent: 10
With the analysis among 8 patents, we discovered top 7 start-ups by total patent application. Juventas Cell Therapy Ltd., Huadao (Shanghai) Biomedical Co., Ltd., Integriculture, Inc. are active in this area.
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 2
Huadao (Shanghai) Biomedical Co., Ltd.
Shanghai Shi, China
Patent: 1
Bretagne, France
Patent: 1
Children's Cancer Therapy Development Institute
Oregon, United States
Patent: 1
CMAB BioPharma (Suzhou) Inc.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 295 patents applied in the last 5 years. We discover 125 most active companies in this area. The fast-growing Boehringer Ingelheim International GmbH, Genzyme Corp., Amgen, Inc. take 19.32% of patent filing during this period.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 27
Massachusetts, United States
Patent: 16
California, United States
Patent: 14
Shanghai Ruiyu Biotech Co., Ltd.
Shanghai Shi, China
Patent: 12
Fukushima-ken, Japan
Patent: 10
New York, United States
Patent: 8
CEVEC Pharmaceuticals GmbH
Nordrhein-Westfalen, Germany
Patent: 8
Newsouth Innovations Pty Ltd.
New South Wales, Australia
Patent: 7
Tianjin Cansino Biotechnology Inc
Tianjin Shi, China
Patent: 5
Shanghai Zhangjiang Biotechnology Co Ltd
Shanghai Shi, China
Patent: 5
With the analysis among related 295 patents in last 5 years, we discover 110 new entrants. Shanghai Ruiyu Biotech Co., Ltd., Able Co., Ltd., Bristol Myers Squibb Co. are the most active new entrants in this area.
Shanghai Ruiyu Biotech Co., Ltd.
Shanghai Shi, China
Patent: 12
Fukushima-ken, Japan
Patent: 10
New York, United States
Patent: 8
CEVEC Pharmaceuticals GmbH
Nordrhein-Westfalen, Germany
Patent: 8
Newsouth Innovations Pty Ltd.
New South Wales, Australia
Patent: 7
Tianjin Cansino Biotechnology Inc
Tianjin Shi, China
Patent: 5
Shanghai Zhangjiang Biotechnology Co Ltd
Shanghai Shi, China
Patent: 5
Shanghai Sinomab Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 5
Shanghai Biomabs Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 5
Suzhou Jiyan Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 5
With the analysis among 128 patents, we discovered top 42 universities and scientific research institutions by total patent application. Beijing Institute of Technology, The Johns Hopkins University, Northwestern University are dominant in this area. They take 14.84% of the total patent filing.
Beijing Institute of Technology
Beijing Shi, China
Patent: 7
The Johns Hopkins University
Illinois, United States
Patent: 6
Stevens Institute of Technology
New Jersey, United States
Patent: 6
East China University of Science & Technology
Shanghai Shi, China
Patent: 5
Dalian Institute of Chemical Physics Chinese Academy of Sciences
Liaoning Sheng, China
Patent: 5
Tokyo Women's Medical University
Lombardia, Italy
Patent: 3
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 3